Preop | Preop | >48 month | >48 month | |
---|---|---|---|---|
Diagnosis | Syst CAI | Topical (No of medications) | Syst CAI | Topical |
*In 3/5 cases the follow up was not completed. 2 cases required systemic CAI and topical treatment, but maintained successful IOP control under that medication. | ||||
Neovascular glaucoma | 8/12 | mean 1.3 | none | 7/12 none |
1/12 drozolamide and β blocking agent | ||||
Trauma | 5/7 | mean 1.5 | none | 4/7 none |
2/7 drozolamide and β blocking agent | ||||
1/7 drozolamide | ||||
Uveitis | 5/7 | mean 2 | none | none (2 patients steroids) |
Glaucoma due to aphakia in congenital cataracts | 8/13 | mean 2.5 | none | 7/13 none |
2/13 drozolamide | ||||
1/13 drozolamide and β blocking agent | ||||
Others | 2/5 | mean 2.8* | 2/5 * | 2/5 triple treatment |
Juvenile and infantile glaucoma, Ehlers-Danlos syndrome |